Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SC0191 in advanced colorectal cancer
NCT06363552Phase 2Not yet recruiting
- Start
- May 2024
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sonkibartinib in metastatic colorectal cancer (mCRC). Planned start May 2024; status: not yet recruiting.
02
Drugs
sonkibartinib
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT06363552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06363552.